Yi-Sheng Huang

Relative Abundance of <i>EGFR</i> Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

Qing Zhou, Xu‐Chao Zhang, Zhihong Chen et al. · Journal of Clinical Oncology · 2011 · 247 citations

Medicine, Oncology, Pharmacology +17

Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial

Jin‐Ji Yang, Caicun Zhou, Yi-Sheng Huang et al. · The Lancet Respiratory Medicine · 2017 · 187 citations

Medicine, Oncology, Radiation Oncology +15

Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer

Jin‐Ji Yang, Hua‐Jun Chen, Hong‐Hong Yan et al. · Lung Cancer · 2012 · 164 citations

Medicine, Oncology, Pharmacology +17

A family history of cancer and lung cancer risk in never-smokers: A clinic-based case–control study

Huan Lin, Yi-Sheng Huang, Hong‐Hong Yan et al. · Lung Cancer · 2015 · 63 citations

Medicine, Oncology, Preventive Medicine +15

Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients

Chao Liu, Yi-Sheng Huang, Yu Chen et al. · Lung Cancer · 2014 · 49 citations

Medicine, Oncology, Pathology +16